Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®
Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®
Recruiting · NCT07663526 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi® | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Phase 4 | 2026-09-24 | NCT07663526 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 88 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fuyang People's Hospital | Fuyang | China | 2 |
| Huai'an First People's Hospital | Huaian | China | 1 |
| Meihekou Central Hospital | Meihekou | China | 3 |
| Shanghai Jiao Tong University School of Medicine, Renji Hospital | Shanghai | China | 1 |
| The Second Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 9 |
| Yancheng No.1 People's Hospital | Yancheng | China | 1 |
| Zhoukou Central Hospital | Zhoukou | China | 7 |